Assessment of risk factors, cost of treatment and therapy outcome in stroke patients: evidence from cross-sectional study.

INTRODUCTION: Increased prevalence of stroke, and the subsequent increased economic burden on the healthcare system and society is a raising concern in India. Objectives of this study were to assess risk factors, cost of treatment and therapy outcomes in stroke patients.

METHODS: This cross-sectional study was conducted in 130 patients of either sex at a government tertiary care hospital of India. Relevant information was collected from available records and through patient interview after permission from ethics committee. National Institute of Health Stroke Score (NIHSS) was used to assess therapy outcome. Analysis of variance and the students t test were applied appropriately where needed.

RESULTS: Higher body mass index, sedentary life style, tobacco use and elevated systolic blood pressure were observed as risk factors in participants. The mean cost of stroke treatment observed at this hospital was Indian Rupee 17934.71(€ 218.70; USD 267.67). Direct medical cost was the principal component in stroke treatment, that ranged from 6% to 27% of the average six-month salary of patients in different socioeconomic classes. A significant improvement (p<0.05) in health outcome (NIHSS Score) observed in participants after treatment.

CONCLUSION: The data on cost of stroke treatment from this study may be used for further pharmacoeconomic studies.